Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbisko, Atyr, Avidity, Briacell, Cyrano, Exegenesis, Hutchmed, Junshi, Krystal, Novavax, Orphagen, Paratek, Pharmather, Sanofi, Scisparc, Takeda.
In what is claimed as the largest study of how digital technologies were applied to support population level research during the pandemic, scientists at the U.K. Medical Research Council’s epidemiology unit at Cambridge University have reported high, sustained levels of engagement in a fully remote COVID-19 study that ran at a time when visits to a study center were not possible.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alithea Genomics, Asahi Kasei, Genetik, Ginkgo Bioworks, Medicines Discovery Catapult, Minxray, Pamgene, Seno Medical Instruments, Smi Drug Discovery, Theralink, Xwell, Zoll.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Astrazeneca, Harbour, Novo Nordisk, Revive.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Biontech, Genentech, Pfizer.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptive Phage, Advaxis, CNS, Midatech, Oramed, Point.
Scripps Research has synthesized 3C-Like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19).
RSS
